Howard Hughes Investigators Named
Three researchers who originally joined the UT Southwestern Medical Center faculty as part of the institution's acclaimed Endowed Scholars Program in Medical Science are among 56 distinguished biomedical scientists nationwide who today were named Howard Hughes Medical Institute investigators.
Berkeley Declares Support For RNs' Contract Campaign At Sutter's Alta Bates Summit
Berkeley city officials voted unanimously in favor of a resolution that calls on Alta Bates Summit Medical Center, in Berkeley and Oakland, to settle the collective bargaining contract with the registered nurses represented by the California Nurses Association.
Flavanols In Cocoa Improve Artery Function, Help Relieve Stress On Heart
For people with diabetes, sipping a mug of steaming, flavorful cocoa may seem a guilty pleasure. But new research suggests that indulging a craving for cocoa can actually help blood vessels to function better and might soon be considered part of a healthy diet for the prevention of cardiovascular disease.
DOR BioPharma Opens New Corporate Office In United Kingdom
DOR BioPharma, Inc. (OTCBB: DORB), a late-stage biopharmaceutical company developing products to treat life-threatening side effects of cancer treatments and serious gastrointestinal diseases, and vaccines against certain bioterrorism agents, announced that it has opened a new corporate office in the United Kingdom (UK).
Bharat Biotech Announces Successful Completion Of Its Phase I II Clinical Trial For 116E Rotavirus Vaccine
The Indian Rotavirus Vaccine Development Project (RVDP) announced encouraging results from a recent Phase I/II clinical trial of a live, natural reassortant, Oral Rotavirus Vaccine 116E (ORV 116E), conducted in New Delhi, India.
Long Term Physiotherapy Denied To Patients With Chronic Conditions, UK
On Wednesday 14 May the Muscular Dystrophy Campaign was joined by 135 supporters, clinicians and healthcare professionals, from around the country, at a Parliamentary reception to lobby Government to improve specialist services for people with neuromuscular conditions.
First EMEA Licensed Treatment Specifically For LGS Offers New Hope For Patients With Epilepsy
Eisai Europe Limited, (Headquarters: London, Chairman and CEO Yutaka Tsuchiya) today announced publication of the results of a major study of its new anti-epileptic agent Inovelon (rufinamide) indicated for adjunctive therapy in Lennox-Gastaut Syndrome (LGS), a severe form of generalised epilepsy that develops in early childhood.
California Lawmakers Seek Tighter Plastic Surgery Rules
Lawmakers in the state senate and assembly of California are pushing for tighter rules to govern plastic surgery after a 58-year-old woman died following breast reduction and other procedures last year.Donda West died in November 2007 in a Los Angeles hospital, a day after having breast reduction, a tummy tuck and liposuction at an outpatient centre.
International Health Professional Associations Present First-ever Guidelines On Incentives For Health Professionals
The world's leading health and hospital professional associations have joined to produce the first-ever joint guidelines on incentives for the retention and recruitment of health professionals.
Mylan Launches Paroxetine Hydrochloride Extended-Release Tablets
Mylan Inc. (NYSE: MYL) announced that Mylan Pharmaceuticals Inc. has launched Paroxetine Hydrochloride (HCl) Extended-release (ER) Tablets, the generic version of GlaxoSmithKline's (GSK) Paxil CR(R). As the first company to successfully file an abbreviated new drug application (ANDA) containing a paragraph IV certification for the 12.